Compare NTRS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRS | IQV |
|---|---|---|
| Founded | 1889 | 1982 |
| Country | United States | United States |
| Employees | 23800 | 93000 |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1B | 28.6B |
| IPO Year | N/A | 2013 |
| Metric | NTRS | IQV |
|---|---|---|
| Price | $172.34 | $167.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $163.55 | ★ $227.13 |
| AVG Volume (30 Days) | 950.5K | ★ 1.5M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $8.40 | $6.77 |
| Revenue Next Year | $4.13 | $5.89 |
| P/E Ratio | ★ $16.88 | $104.26 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $118.99 | $154.50 |
| 52 Week High | $176.99 | $247.05 |
| Indicator | NTRS | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 39.76 |
| Support Level | $165.90 | $159.53 |
| Resistance Level | $172.36 | $182.20 |
| Average True Range (ATR) | 4.03 | 6.35 |
| MACD | 0.06 | -1.70 |
| Stochastic Oscillator | 62.31 | 19.50 |
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2025, Northern Trust had assets under custody or administration of $18.7 trillion and assets under management of $1.8 trillion.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.